JDD July 2024 Issue Highlights
This July, the Journal of Drugs in Dermatology (JDD) is proud to present a special edition focused on “Bridging the Gap in Dermatology.” Our Editor’s Picks this month highlight groundbreaking research and discussions aimed at promoting inclusivity, representation, and innovation in dermatologic care. From advancements in sun protection to the role of social media in …
Urticaria Pigmentosa Without Pruritus | Case Report
Mastocytosis is a group of disorders characterized by the pathologic accumulation of mast cells in various tissues. One example of mastocytosis is urticaria pigmentosa, which presents with mastocytomas that can cause hives and, when irritated, pruritus. To the authors’ knowledge, they are describing the first case of urticaria pigmentosa without pruritus. The patient had a …
Continue reading “Urticaria Pigmentosa Without Pruritus | Case Report”
JDD Buzz Series | Sunscreen Practices & Preferences in Skin of Color Patients
Sunscreen use varies among different racial groups despite its scientifically proven benefits. A cross-sectional, questionnaire-based study in the June issue of the Journal of Drugs in Dermatology aims to understand the needs and challenges people with skin of color face when choosing and using sunscreen. I interviewed author Jared Jagdeo, MD, MS, associate professor of …
Continue reading “JDD Buzz Series | Sunscreen Practices & Preferences in Skin of Color Patients”
Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata | Case Report
Alopecia areata (AA) is a common autoimmune disorder. Although its pathogenesis is not fully understood, AA involves CD8 T cell-mediated destruction of the hair follicle. Several treatment options exist; however, there is minimal evidence in the pediatric population. Currently, there are no curative treatments for AA. The literature suggests that Janus kinase (JAK) inhibitors may …
JDD June 2024 Issue Highlights
In this June edition of the Journal of Drugs in Dermatology (JDD), we’re excited to showcase a selection of groundbreaking research and expert insights that delve into the latest advancements and treatments in dermatology. From innovative acne scar therapies to in-depth analyses of topical acne treatments, this month’s featured articles provide a comprehensive overview of …
JDD Buzz Series | PIH Following Mohs Micrographic Surgery
Mohs Micrographic Surgery effectively removes skin cancer while preserving healthy tissue. But what happens when the procedure that’s supposed to help maintain aesthetics leads to long-lasting and highly distressing cosmetic outcomes? That’s the focus of an observational study published in the May issue of the Journal of Drugs in Dermatology. Researchers looked at the factors …
Continue reading “JDD Buzz Series | PIH Following Mohs Micrographic Surgery”
JDD Buzz Series | Melasma in Men
Tranexamic acid is one of the latest therapies for treating melasma, and one that’s most commonly prescribed for women. An editorial published in the April issue of the Journal of Drugs in Dermatology encourages dermatology clinicians to also consider the effect melasma has on men and to utilize tranexamic acid as a treatment option. I …
A Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma
ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and extranodal involvement is seen in approximately 40% of cases. However, cases involving the skin and muscle are rare, and skin manifestations most commonly present as plaques, papules, small nodules, or ulcers. In this report, JDD authors Lauren E. Merz MD …
Continue reading “A Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma”
JDD April 2024 Issue Highlights
Introducing the April 2024 Editorial Highlights from the Journal of Drugs in Dermatology! This month’s issue is packed with groundbreaking research and insights into dermatologic treatments and practices. From original articles exploring innovative therapies for conditions like photoaging and acne vulgaris to case reports shedding light on rare dermatologic phenomena, this issue offers a comprehensive …
Post-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report
ABSTRACT Post-hyaluronic acid filler nodules are uncommon, unpredictable complications that present a challenge to clinical therapy. JDD authors Miyahra Haniko P. Lopez MD MBA, Sophie H. Guenin MSc, Jennifer Laborada BS, and Mark G. Lebwohl MD report a case of a female in her fifties who developed edema and nodules 6 weeks after hyaluronic acid …
Continue reading “Post-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report”